Generic Drugmakers Thwarted Competition On Topical Drugs, Suit Alleges

The suit, filed Wednesday in federal court by more than four dozen attorneys general, accuses 26 generic drug companies and 10 executives of keeping prices artificially high for the drugs. It is the third in a series of antitrust lawsuits targeting the industry.

Leave a Reply

Your email address will not be published. Required fields are marked *